Myriad Genetics, Inc. (NASDAQ:MYGN) Director Daniel K. Spiegelman Sells 8,638 Shares

Myriad genetics logo

Daniel K. Spiegelman, principal of Myriad Genetics, Inc. (NASDAQ:MYGN – Get Rating), sold 8,638 shares in a deal on Friday, June 2. The stock sold at an average price of $23.01, for a total transaction of $198,760.38. As a result of the sale, the director now owns 40,493 shares of the company, valued at approximately … Read more

37,393 shares of Myriad Genetics, Inc. (NASDAQ:MYGN) purchased by HRT Financial LP

Myriad genetics logo

HRT Financial LP acquired a new stake in Myriad Genetics, Inc. (NASDAQ: MYGN – Get Rating) in the fourth quarter, according to its latest Form 13F filed with the Securities and Exchange Commission. The institutional investor acquired 37,393 shares of the company, valued at approximately $542,000. Other institutional investors and hedge funds have also recently … Read more

Dimensional Fund Advisors LP has a $23.78 million stake in Fulgent Genetics, Inc. (NASDAQ:FLGT)

Fulgent genetics logo

Dimensional Fund Advisors LP increased its stake in Fulgent Genetics, Inc. (NASDAQ: FLGT – Get Rating) by 17.3 percent in the 4th quarter, according to the company in its latest SEC filing. The fund owned 798,326 shares of the company after purchasing an additional 117,504 shares during the quarter. Dimensional Fund Advisors LP owned approximately … Read more